Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry

EPICOVIDEHA study group, Tommaso Francesco Aiello, Jon Salmanton-García*, Francesco Marchesi, Barbora Weinbergerová, Andreas Glenthøj, Jens Van Praet, Francesca Farina, Julio Dávila-Valls, Sonia Martín-Pérez, Shaimaa El-Ashwah, Martin Schönlein, Iker Falces-Romero, Jorge Labrador, Uluhan Sili, Caterina Buquicchio, Antonio Vena, Gaëtan Plantefeve, Verena Petzer, Monika M. BiernatTobias Lahmer, Ildefonso Espigado, Jaap Van Doesum, Ola Blennow, Klára Piukovics, Carlo Tascini, Michail Samarkos, Yavuz M. Bilgin, Luana Fianchi, Federico Itri, Toni Valković, Nicola S. Fracchiolla, Michelina Dargenio, Moraima Jiménez, Ferenc Magyari, Alberto López-García, Lucia Prezioso, Natasha Čolović, Evgenii Shumilov, Ghaith Abu-Zeinah, Carolin Krekeler, Esperanza Lavilla-Rubira, Mario Virgilio Papa, Tomás José González-López, László Imre Pinczés, Fatih Demirkan, Natasha Ali, Caroline Besson, Guillemette Fouquet, Maria Gomes Da Silva, Emanuele Ammatuna, Livio Pagano

*Corresponding author voor dit werk

    OnderzoeksoutputAcademicpeer review

    2 Citaten (Scopus)
    9 Downloads (Pure)
    Originele taal-2English
    Pagina's (van-tot)2693-2700
    Aantal pagina's8
    TijdschriftHaematologica
    Volume109
    Nummer van het tijdschrift8
    DOI's
    StatusPublished - aug.-2024

    Citeer dit